[{"address1": "Tesbury Centre", "address2": "Suite 901 28 Queen\u2019s Road East", "city": "Wanchai", "country": "Hong Kong", "phone": "852 400 086 9570", "website": "https://www.zybioholdings.com", "industry": "Packaged Foods", "sector": "Consumer Defensive", "longBusinessSummary": "Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company's products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life's NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement. It sells its products under the Muzhiyuan-Neuro Enhancer brand. The company Limited is based in Wanchai, Hong Kong.", "fullTimeEmployees": 35, "companyOfficers": [{"maxAge": 1, "name": "Ms. Ting Ting  Chang", "age": 33, "title": "President, CEO, Secretary & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 17520, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Fung Ming  Pang FCPA", "age": 53, "title": "CFO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 72000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xianyang  Chen", "age": 39, "title": "Chief Technical Officer of Bao Feng", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yu  Gao", "age": 39, "title": "Chief Marketing Officer of Bao Feng", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 17520, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.34, "open": 2.34, "dayLow": 2.34, "dayHigh": 2.34, "regularMarketPreviousClose": 2.34, "regularMarketOpen": 2.34, "regularMarketDayLow": 2.34, "regularMarketDayHigh": 2.34, "beta": 3.757, "volume": 1, "regularMarketVolume": 1, "averageVolume": 6, "bid": 2.33, "ask": 4.9, "askSize": 40000, "marketCap": 88321000, "fiftyTwoWeekLow": 1.47, "fiftyTwoWeekHigh": 6.0, "priceToSalesTrailing12Months": 35.415195, "fiftyDayAverage": 4.9866, "twoHundredDayAverage": 4.5924, "currency": "USD", "enterpriseValue": 90548936, "profitMargins": -0.12168, "floatShares": 3836392, "sharesOutstanding": 17699600, "heldPercentInsiders": 0.64927, "bookValue": 0.014, "priceToBook": 356.42856, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -303463, "trailingEps": -0.02, "enterpriseToRevenue": 36.309, "enterpriseToEbitda": -280.738, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "ZHYBF", "underlyingSymbol": "ZHYBF", "shortName": "ZHONG YUAN BIO-TECHNOLOGY HLDGS", "longName": "Zhong Yuan Bio-Technology Holdings Limited", "firstTradeDateEpochUtc": 1622813400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "857ab231-a3cb-352a-aba8-47fb3e1d69f8", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.99, "recommendationKey": "none", "totalCash": 76618, "totalCashPerShare": 0.004, "ebitda": -322539, "totalDebt": 2308235, "quickRatio": 0.553, "currentRatio": 0.868, "totalRevenue": 2493873, "debtToEquity": 925.437, "revenuePerShare": 0.141, "returnOnAssets": -0.07035, "returnOnEquity": -1.00661, "grossMargins": 0.85836, "ebitdaMargins": -0.12933, "operatingMargins": 0.1915, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]